Manulife US REIT (SGX:BTOU) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


What is Manulife US REIT Research & Development?

Manulife US REIT SGX:BTOU -1.89% Research & Development is $0.0 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Manulife US REIT's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Manulife US REIT  (SGX:BTOU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Manulife US REIT Research & Development Related Terms

Manulife US REIT Research & Development Historical Data

* Premium members only.

The historical data trend for Manulife US REIT's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Manulife US REIT Research & Development Chart

Manulife US REIT Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Manulife US REIT Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Manulife US REIT Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Manulife US REIT (SGX:BTOU) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Manulife US REIT and its competitors.
Is Manulife US REIT's Research & Development too high?
Manulife US REIT's current Research & Development is $0.0 Mil.
How does Manulife US REIT's Research & Development compare to BXP and ARE?
Manulife US REIT's Research & Development of $0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Manulife US REIT and its competitors. Manulife US REIT's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Manulife US REIT stock overvalued right now?
Based on GuruFocus' analysis, Manulife US REIT (SGX:BTOU) is currently considered Fairly Valued. The stock's GF Value™ is $0.05, compared to a current price of $0.05 — trading 4% above its estimated fair value. The current Research & Development is $0.0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Manulife US REIT (SGX:BTOU), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Manulife US REIT Business Description

Industry Real EstateREITs
Address 8 Cross Street, No.16-03 Manulife Tower, Singapore, SGP, 048424
Manulife US REIT is a pure-play U.S. office REIT in Asia. The company along with its subsidiaries invests, directly or indirectly, in a portfolio of income-producing office real estate in markets in the U.S., as well as real estate-related assets. The Group's investment properties comprise commercial office properties. Some of its properties include Figueroa and Michelson in California along with Plaza and Exchange in New Jersey. Geographically, the majority is derived from the United States.